2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia,European Heart Journal

当前位置： X-MOL 学术 › Eur. Heart J. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia
European Heart Journal ( IF 37.6 ) Pub Date : 2017-10-16 , DOI: 10.1093/eurheartj/ehx549
Ulf Landmesser ₁ , M John Chapman ₂ , Jane K Stock ₃ , Pierre Amarenco ₄ , Jill J F Belch ₅ , Jan Borén ₆ , Michel Farnier ₇ , Brian A Ference ₈ , Stephan Gielen ₉ , Ian Graham ₁₀ , Diederick E Grobbee ₁₁ , G Kees Hovingh ₁₂ , Thomas F Lüscher ₁₃ , Massimo F Piepoli ₁₄ , Kausik K Ray ₁₅ , Erik S Stroes ₁₂ , Olov Wiklund ₁₆ , Stephan Windecker ₁₇ , Jose Luis Zamorano ₁₈ , Fausto Pinto ₁₉ , Lale Tokgözoğlu ₂₀ , Jeroen J Bax ₂₁ , Alberico L Catapano ₂₂

Affiliation

Department of Cardiology, Charite Universitätsmedizin Berlin, Berlin Institute of Health (BIH), German Center of Cardiovascular Research (DZHK), Hindenburgdamm 30, 12203 Berlin, Germany
National Institute for Health and Medical Research (INSERM), University of Pierre and Marie Curie, Pitié-Salpêtrière Hospital, Paris, France
European Atherosclerosis Society, Gothenburg, Sweden
Paris-Diderot-Sorbonne University and Department of Neurology and Stroke Centre, Bichat Hospital, Paris, France
Institute of Cardiovascular Research, Ninewells Hospital and Medical School, Dundee, UK
Department of Molecular and Clinical Medicine, University of Gothenburg and Sahlgrenska University Hospital, and Wallenberg Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden
Lipid Clinic, Point Medical, and Department of Cardiology, CHU Dijon-Bourgogne, Dijon, France
Division of Cardiovascular Medicine, Division of Translational Research and Clinical Epidemiology, Wayne State University School of Medicine, Detroit, MI, USA
Department of Internal Medicine III, Martin-Luther-University Halle/Wittenberg, University Hospital, Halle/Saale, Germany
Trinity College, Dublin, Ireland
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
University Heart Center, Department of Cardiology, University Hospital Zurich, and Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland
Heart Failure Unit, Cardiac Department, G Da Saliceto Hospital, Piacenza, Italy
Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College, London, UK
Sahlgrenska University Hospital, Gothenburg, Sweden
Department of Cardiology, Swiss Cardiovascular Center Bern, Bern University Hospital, Bern, Switzerland
Department of Cardiology, University Hospital Ramón y Cajal, Madrid, Spain
Cardiology Department, CCUL, CAML, Faculdade de Medicina, Universidade de Lisboa, Portugal
Department of Cardiology, Hacettepe University, Ankara, Turkey
Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands
Department of Pharmacological and Biomolecular Sciences, University of Milan and Multimedica IRCSS Milano, Italy